BN Business News
Add your company to Business Communicator →

Business · 28/05/2026

FDA Extends Comment Period for AI-Enabled Clinical Trials Pilot Program

The FDA is extending the comment period for a notice on using artificial intelligence to improve early-phase clinical trials, in response to a request for an extension, to gather more input from interested persons.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights